NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » Industry News » Expected surge in endoscopic haemostasis devices sales will not offset Covid-19 revenue losses until next year » shutterstock_296622788

Expected surge in endoscopic haemostasis devices sales will not offset Covid-19 revenue losses until next year

NS Medical Devices is using cookies

Endoscopic haemostasis devices are used to manage gastrointestinal bleeding (Credit: Liya Graphics/Shutterstock)

Related Article

NCCID: The national database being used to harness AI and help tackle Covid-19 more effectively in the UK

RECOMMENDED COMPANIES

MOST READ

NCCID: The national database being used to harness AI and help tackle Covid-19 more effectively in the UK

New ‘nano-popcorn’ substrate could enhance respiratory virus biosensors

Ten major players in the global in vitro diagnostics market right now

Geko: How the DVT prevention device was developed and improved over its lifecycle

How have lockdowns and social distancing impacted the way medical device manufacturers are regulated?

Recommended Whitepaper